Skip to main content
Equibles
INFU logo

INFU · InfuSystem Holdings, Inc · Metrics

Track INFU — free

Use INFU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INFU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.51 +0.19 (+1.33%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$285.21M
Shares
19.92M
Volume · Oct 29 36.91K Avg daily vol (3M) 138.93K

INFU metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.32
Market cap
$285.21M

Price action

20 metrics
Price change (1W)
+1.9%
Price change (30D)
+9.9%
Price change (3M)
+46.7%
Price change (6M)
+45.7%
Price change (YTD)
+59.6%
Price change (1Y)
+37.0%
Trailing year
Price change (5Y)
-8.4%
52-week high
$14.32
52-week low
$7.42
Change from 52-week high
+0.0%
Change from 52-week low
+93.0%
Annualized volatility
57.4%
Annualized volatility (3M)
72.3%
Beta
1.2
RSI (14D)
65.5
Price vs SMA 50
+11.1%
Price vs SMA 200
+39.4%
Avg volume (3M)
138,929
Relative volume
1.0
Average dollar volume
$1.73M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
19.92M

Valuation

12 metrics
P / E (TTM)
35.8
Trailing earnings · reciprocal yield 2.8%
PEG ratio
1.4
EV / revenue
2.1×
reciprocal yield 47.6%
EV / EBITDA
11.4×
reciprocal yield 8.8%
EV / EBIT
22.7×
reciprocal yield 4.4%
P / sales
2.0×
reciprocal yield 50.9%
P / book
4.8
reciprocal yield 21.0%
FCF yield
8.1%
TTM · current market cap
Buyback yield
2.8%
P / FCF
12.3
reciprocal yield 8.1%
P / operating cash flow
12.0
reciprocal yield 8.3%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
168.3×
reciprocal yield 0.6%
P / E historical average (5Y)
219.8×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 68.3%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.5%
EV / EBIT historical average (3Y)
34.4×
reciprocal yield 2.9%
EV / EBIT historical average (5Y)
69.4×
reciprocal yield 1.4%
EV / EBITDA historical average (3Y)
10.0×
reciprocal yield 10.0%
EV / EBITDA historical average (5Y)
12.0×
reciprocal yield 8.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
57.5%
Operating margin
9.3%
Trailing 12 months
Net margin
6.0%
Gross profit (TTM)
$82.35M
Operating profit (TTM)
$13.27M
Net income (TTM)
$8.54M
Trailing 12 months
Diluted EPS (TTM)
$0.40
FCF margin
16.0%
Effective tax rate
30.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$6.82
Gross profit per diluted share (TTM)
$3.92
Operating profit per diluted share (TTM)
$0.63
EBITDA per diluted share (TTM)
$1.25
Net income per diluted share (TTM)
$0.41
Operating cash flow per diluted share (TTM)
$1.11
Free cash flow per diluted share (TTM)
$1.09
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.24
Book value per share
$2.84

Growth

11 metrics
Revenue growth YoY
+2.6%
Year over year
Net income growth YoY
+24.3%
Revenue (TTM)
$143.34M
Trailing 12 months
EPS growth YoY
+25.0%
Shares change YoY
-0.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.3%
Revenue CAGR (5Y)
+8.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-17.3%
FCF CAGR (3Y)
+13.0%
FCF CAGR (5Y)
+4.4%

Quality

14 metrics
Return on equity
14.4%
Return on assets
8.7%
Debt / equity
0.3
Current ratio
2.5
EBITDA (TTM)
$26.33M
Free cash flow (TTM)
$22.91M
Quick ratio
2.1
Interest coverage
12.1
Net debt / EBITDA
0.7
Return on invested capital
11.8%
Trailing 12 months
Net cash
−$19.46M
Latest balance sheet
Cash & equivalents
$964,000
Total assets
$97.70M
Total debt
$20.42M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$23.37M
Capital expenditures (TTM)
$460,000
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.07M
R&D / revenue
—
Stock compensation / revenue
3.5%

Ownership (13F)

9 metrics
13F filers
100
13F filer change QoQ
+4
Institutional ownership
75.9%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
38.8%
Private-fund adviser ownership
38.1%
Active holders' share change QoQ
-4.4%
Holder tenure
13.6
Price vs estimated holder cost
+9.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.1%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1337013 CUSIP 45685K102 13F (30d) 14 filings 14 filers Visit website Investor relations